Kanagawa, Japan

Hideki Nishitoh

This inventor holds 1 USPTO granted patent. Top assignees: Creative Biomolecules, Inc., Ludwig Institute for Cancer Research Limited. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideki Nishitoh

Introduction

Hideki Nishitoh is a notable inventor based in Kanagawa-ken, Japan. He has made significant contributions to the field of molecular biology, particularly in the study of morphogen receptors. His work has implications for therapeutic and diagnostic applications.

Latest Patents

Nishitoh holds a patent for a "Method for identifying an OP-1 analog which binds an ALK-1 receptor." This patent discloses various nucleic acid sequences, amino acid sequences, and structural features that characterize morphogen cell surface receptors. It also includes methods for producing receptor proteins using recombinant DNA technology, identifying novel morphogen receptors, and discovering compounds that can modulate endogenous morphogen receptor levels. The patent outlines methods and compositions for identifying and producing morphogen analogs useful in designing morphogen agonists and antagonists for various applications.

Career Highlights

Throughout his career, Hideki Nishitoh has worked with several prominent organizations. He has been associated with Creative Biomolecules, Inc. and the Ludwig Institute for Cancer Research Limited. His work in these institutions has furthered research in cancer and molecular biology.

Collaborations

Nishitoh has collaborated with notable colleagues, including Hidenori Ichijo and Kuber T Sampath. These collaborations have contributed to advancements in their respective fields.

Conclusion

Hideki Nishitoh's innovative work in identifying morphogen receptors and their analogs has made a significant impact in molecular biology. His contributions continue to influence therapeutic and diagnostic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…